An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
恢复卵巢癌卡铂敏感性的表观遗传学策略
基本信息
- 批准号:8627405
- 负责人:
- 金额:$ 32.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-14 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectBioinformaticsBiological MarkersBiopsyCancer ModelCarboplatinClinicalClinical Trials DesignCorrelative StudyDNADNA MethylationDNA mappingDecitabineDevelopmentDiseaseDrug resistanceEnrollmentEpigenetic ProcessEventFDA approvedFutureGenesGeneticGoalsHematologic NeoplasmsHistone DeacetylationInterventionLiposomesMalignant NeoplasmsMalignant neoplasm of ovaryMassive Parallel SequencingMeasuresMethylationOutcomePaclitaxelPatientsPharmacologic SubstancePhase II Clinical TrialsPhase III Clinical TrialsPhysiciansPlasmaPlatinumPre-Clinical ModelPrimary NeoplasmProtocols documentationRandomizedRecurrenceRegimenRelapseResearch DesignResearch PersonnelResistanceSamplingSolid NeoplasmSpecimenStagingSurvival RateTestingTherapeutic Clinical TrialTherapeutic InterventionTimeTopotecanTransferaseTreatment outcomeTumor Suppressor ProteinsWomanWorkbasecancer initiationcancer therapychemotherapyclinically relevantdensitydesignepigenomeepigenomicsgene discoveryhistone modificationinhibitor/antagonistinnovationmethylomenovelpublic health relevanceresponseresponse markertreatment strategytrial comparingtumortumor progression
项目摘要
Project Summary/Abstract
Platinum resistance in ovarian cancer is associated with accumulation of epigenetic changes leading to
transcriptional silencing of tumor suppressor and chemo-responsiveness-associated genes. A clinical trial
designed and conducted previously demonstrated that methylome-targeted interventions reverse platinum
resistance and induce clinical responses. Building upon this work, we propose to extend the ovarian cancer
epigenome analysis by using MBDCap-sequencing and bioinformatics and to test the effects of SGI-110, a
novel DNA methyl transferase inhibitor (DNMTI). The hypothesis to be tested is that platinum resistance in
ovarian cancer is uniquely reflected in DNA methylation changes and can be reversed by DNMTI. To
address this hypothesis, tumor and plasma samples collected from an ongoing randomized phase II clinical trial
comparing SGI-110 and carboplatin to FDA-approved strategies for platinum-resistant ovarian cancer will be
analyzed. Clinical specimens from ~100 patients will be available for analysis. Three aims are proposed. For
Aim 1, DNMTI-induced changes in the ovarian cancer methylome will be measured by using MethylCap-seq on
tumor biopsies obtained before and after SGI-110. The objective of this Aim is to investigate whether SGI-110
induces global methylome changes affecting networks of genes associated with chemo-responsiveness. The
objective of Aim 2 is to determine whether DNMT expression levels differ in recurrent vs. primary tumors and
whether expression levels at enrollment or changes induced by DNMTIs correlate with clinical benefit. For Aim
3, the objective is to determine whether specific genes methylation levels at enrollment and changes induced by
DNMTIs correlate with clinical benefit. This project will identify critical DNA methylation events that govern the
development of platinum resistance. The proposed studies are highly innovative based on the use of state-of-
the-art MBDCap-Seq and bioinformatics applied to a question of high clinical relevance. Successful completion
of the correlative work integrated in this trial will identify predictive markers of response to methylome-targeting
strategies. This study will bring epigenetic interventions to the forefront of therapy for ovarian cancer impacting
treatment strategies and outcomes for this deadly cancer. Successful completion of this study will move
forward the field of epigenome-targeted therapy for solid tumors and will provide key information for biologically-
directed future design of phase III trials.
项目摘要/摘要
卵巢癌中铂耐药与表观遗传改变的积累有关
肿瘤抑制基因和化疗反应相关基因的转录沉默。一项临床试验
之前设计和进行的研究表明,甲基组靶向干预逆转了铂
耐药并诱导临床反应。在这项工作的基础上,我们建议延长卵巢癌
应用MBDCap测序和生物信息学进行表观基因组分析及验证SGI-110的作用
新型DNA甲基转移酶抑制剂(DNMTI)。需要检验的假设是,铂金阻力在
卵巢癌独特地反映在DNA甲基化的变化上,并可以通过DNMTI逆转。至
从正在进行的随机二期临床试验中收集的肿瘤和血浆样本解决了这一假设
将SGI-110和卡铂与FDA批准的治疗铂耐药卵巢癌的策略进行比较
分析过了。将提供约100名患者的临床样本进行分析。提出了三个目标。为
目的1,用甲基帽序列技术检测DNMTI诱导的卵巢癌细胞甲基组的变化
SGI-110前后的肿瘤活检标本。此目的是调查SGI-110是否
诱导全球甲基组变化,影响与化学反应相关的基因网络。这个
目标2的目的是确定DNMT在复发肿瘤和原发肿瘤中的表达水平是否不同
登记时的表达水平或由DNMTI引起的变化是否与临床益处相关。为了达到目标
3,目标是确定特定基因在注册时的甲基化水平和由
DNMTIs与临床益处相关。该项目将确定关键DNA甲基化事件
铂电阻的发展。拟议的研究具有很高的创新性,基于对状态的使用
最先进的MBDCap-Seq和生物信息学应用于一个具有高度临床相关性的问题。成功完成
在这项试验中整合的相关工作将确定对甲基组靶向反应的预测标记
战略。这项研究将把表观遗传学干预带入卵巢癌治疗的前沿。
这种致命癌症的治疗策略和结果。这项研究的成功完成将使
推进表观基因组靶向治疗实体肿瘤领域,并将为生物学上的
指导第三阶段试验的未来设计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniela E Matei其他文献
Daniela E Matei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniela E Matei', 18)}}的其他基金
Understanding Metabolic Reprogramming in Platinum Resistant Ovarian Cancer
了解铂类耐药卵巢癌的代谢重编程
- 批准号:
10485428 - 财政年份:2022
- 资助金额:
$ 32.37万 - 项目类别:
Project 02: Tumor Methylomics Analysis Link with Racial Disparities in Ovarian Cancer
项目02:肿瘤甲基组学分析与卵巢癌种族差异的联系
- 批准号:
10488640 - 财政年份:2020
- 资助金额:
$ 32.37万 - 项目类别:
Project 02: Tumor Methylomics Analysis Link with Racial Disparities in Ovarian Cancer
项目02:肿瘤甲基组学分析与卵巢癌种族差异的联系
- 批准号:
10265428 - 财政年份:2020
- 资助金额:
$ 32.37万 - 项目类别:
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
恢复卵巢癌卡铂敏感性的表观遗传学策略
- 批准号:
8806535 - 财政年份:2014
- 资助金额:
$ 32.37万 - 项目类别:
Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer
组织动力学成像对卵巢癌治疗效果的影响
- 批准号:
9085110 - 财政年份:2013
- 资助金额:
$ 32.37万 - 项目类别:
Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer
组织动力学成像对卵巢癌治疗效果的影响
- 批准号:
8656327 - 财政年份:2013
- 资助金额:
$ 32.37万 - 项目类别:
Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer
组织动力学成像对卵巢癌治疗效果的影响
- 批准号:
8471381 - 财政年份:2013
- 资助金额:
$ 32.37万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 32.37万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 32.37万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 32.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 32.37万 - 项目类别:
Studentship